BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36091074)

  • 1. Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.
    Chen Y; Qin Y; Wu Y; Wei H; Wei Y; Zhang Z; Duan T; Jiang H; Song B
    Front Immunol; 2022; 13():973153. PubMed ID: 36091074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
    Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
    Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
    Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
    Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Wei H; Jiang H; Qin Y; Wu Y; Lee JM; Yuan F; Zheng T; Duan T; Zhang Z; Qu Y; Chen J; Chen Y; Ye Z; Yao S; Zhang L; Yang T; Song B
    Eur Radiol; 2022 Nov; 32(11):7578-7589. PubMed ID: 35554652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma.
    Song Y; Zhang YY; Yu Q; Chen T; Wei CG; Zhang R; Hu W; Qian XJ; Zhu Z; Zhang XW; Shen JK
    Front Oncol; 2023; 13():1123141. PubMed ID: 36824129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics on Gadoxetate Disodium-enhanced MRI: Non-invasively Identifying Glypican 3-Positive Hepatocellular Carcinoma and Postoperative Recurrence.
    Chong H; Gong Y; Zhang Y; Dai Y; Sheng R; Zeng M
    Acad Radiol; 2023 Jan; 30(1):49-63. PubMed ID: 35562264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI.
    Yang T; Wei H; Wu Y; Qin Y; Chen J; Jiang H; Song B
    Insights Imaging; 2023 Jan; 14(1):3. PubMed ID: 36617583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
    Sun L; Mu L; Zhou J; Tang W; Zhang L; Xie S; Chen J; Wang J
    Cancer Immunol Immunother; 2022 Jan; 71(1):25-38. PubMed ID: 33993366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma.
    Wu CH; Lee YH; Liang PC; Hu RH; Shih TT; Ho MC
    J Formos Med Assoc; 2022 Aug; 121(8):1550-1559. PubMed ID: 35033411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
    Yan M; Zhang X; Zhang B; Geng Z; Xie C; Yang W; Zhang S; Qi Z; Lin T; Ke Q; Li X; Wang S; Quan X
    Eur Radiol; 2023 Jul; 33(7):4949-4961. PubMed ID: 36786905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.
    Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C
    Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System.
    Yang J; Jiang H; Xie K; Bashir MR; Wan H; Huang J; Qin Y; Chen J; Lu Q; Song B
    Eur J Radiol; 2022 Sep; 154():110397. PubMed ID: 35696735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Glypican-3 Expression in Hepatocellular Carcinoma by Using IDEAL IQ Magnetic Resonance Imaging.
    Chen R; Bai Y; Liu T; Zhang G; Han Y; Chen L; Gao H; Wei W; Wang M
    Acad Radiol; 2021 Aug; 28(8):e227-e234. PubMed ID: 32540197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
    Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
    World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study.
    Jiang H; Song B; Qin Y; Konanur M; Wu Y; McInnes MDF; Lafata KJ; Bashir MR
    J Magn Reson Imaging; 2022 Aug; 56(2):399-412. PubMed ID: 34994029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
    Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Li J; Wang J; Lei L; Yuan G; He S
    Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.